Grant: Discovery Grants Program - Individual
University of Toronto
$38,000.00
The effects of phage defense on recombinant protein expression
EF 2014-15
Résumé
To generate large quantities of proteins used for biotechnology applications, it is usually necessary to express the protein as a ""recombinant"" product in an organism distinct from the original source (e.g. producing a human protein in a bacterial cell). This is necessary because it is generally difficult to obtain adequate quantities of protein from native sources. When practical, bacterial systems are ideal because bacteria grow rapidly, bacterial growth medium is inexpensive, bacterial physiology is relatively well understood, and several strains of genetically modified bacteria have been developed that can produce high-quality, intact recombinant proteins. Despite the development of techniques for protein production in bacterial systems, it is still difficult to obtain high-yields of certain proteins for unknown reasons. This is particularly true when attempting the production of proteins from higher organisms such as humans, due to the small but significant differences in human gene structure compared to bacteria. In 2000 the sales of the 30 leading recombinant proteins exceeded $13 billion, $5.6 billion of which were produced in E. coli. Advances that make it easier to express or increase yield of recombinant proteins would be of considerable interest to a large number of important industries.We believe bacteria are rigged to reject DNA that comes from outside sources (i.e. is foreign). Bacteria do this to protect themselves against viruses that infect bacterial cells called phages, but as a result of this tendency they also reject DNA that comes from recombinant DNA. We are determining how phages avoid the bacterial immune response to see if we can develop bacteria that no longer have the capacity to reject foreign DNA. We believe that in doing so the bacteria will be better making recombinant proteins from foreign sources (including human proteins or other proteins used in food or industrial purposes).
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
386286-2010
Name nom
Navarre, William
Department département
Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
38000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
5
Nb partie
5
Application title
The effects of phage defense on recombinant protein expression
Keyword
NSERC
Application summary
To generate large quantities of proteins used for biotechnology applications, it is usually necessary to express the protein as a ""recombinant"" product in an organism distinct from the original source (e.g. producing a human protein in a bacterial cell). This is necessary because it is generally difficult to obtain adequate quantities of protein from native sources. When practical, bacterial systems are ideal because bacteria grow rapidly, bacterial growth medium is inexpensive, bacterial physiology is relatively well understood, and several strains of genetically modified bacteria have been developed that can produce high-quality, intact recombinant proteins. Despite the development of techniques for protein production in bacterial systems, it is still difficult to obtain high-yields of certain proteins for unknown reasons. This is particularly true when attempting the production of proteins from higher organisms such as humans, due to the small but significant differences in human gene structure compared to bacteria. In 2000 the sales of the 30 leading recombinant proteins exceeded $13 billion, $5.6 billion of which were produced in E. coli. Advances that make it easier to express or increase yield of recombinant proteins would be of considerable interest to a large number of important industries.We believe bacteria are rigged to reject DNA that comes from outside sources (i.e. is foreign). Bacteria do this to protect themselves against viruses that infect bacterial cells called phages, but as a result of this tendency they also reject DNA that comes from recombinant DNA. We are determining how phages avoid the bacterial immune response to see if we can develop bacteria that no longer have the capacity to reject foreign DNA. We believe that in doing so the bacteria will be better making recombinant proteins from foreign sources (including human proteins or other proteins used in food or industrial purposes).